Home Novo Nordisk to end German sales of new insulin drug after price row
 

Keywords :   


Novo Nordisk to end German sales of new insulin drug after price row

2015-07-01 20:23:39| Biotech - Topix.net

COPENHAGEN: Denmark's Novo Nordisk, the world's biggest insulin producer, is to stop selling its new long-acting insulin drug Tresiba in Germany following a row over pricing. The decision is the latest example of tensions between drugmakers and healthcare providers, many of whom are unhappy about the high cost of modern medicines.

Tags: price end sales german

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11SEVENTEEN weverse global
14.11RR3118 Calfoot EMS
14.11
14.11PS1 DANGAN
14.117 10 MP1000 A
14.11MYOJO 54 + MYOJO9()
14.11TWICE With YOU-th nemo ver 3
14.11
More »